Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
Pneumologie (Stuttgart, Germany) - 74(2020), 9 vom: 01. Sept., Seite 611-614 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Renin-Angiotensin-System (RAS) und COVID-19 |
|---|
| Beteiligte Personen: |
Kreutz, R [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 18.09.2020 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/a-1165-6994 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314889132 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314889132 | ||
| 003 | DE-627 | ||
| 005 | 20231225153720.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1055/a-1165-6994 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1049.xml |
| 035 | |a (DE-627)NLM314889132 | ||
| 035 | |a (NLM)32916743 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Kreutz, R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers |
| 246 | 3 | 3 | |a Renin-Angiotensin-System (RAS) und COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.09.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Angiotensin-Converting Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Angiotensins |2 NLM | |
| 650 | 7 | |a Receptors, Virus |2 NLM | |
| 650 | 7 | |a Peptidyl-Dipeptidase A |2 NLM | |
| 650 | 7 | |a EC 3.4.15.1 |2 NLM | |
| 650 | 7 | |a ACE2 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 650 | 7 | |a Renin |2 NLM | |
| 650 | 7 | |a EC 3.4.23.15 |2 NLM | |
| 700 | 1 | |a Abd El-Hady Algharably, E |e verfasserin |4 aut | |
| 700 | 1 | |a Ganten, D |e verfasserin |4 aut | |
| 700 | 1 | |a Messerli, F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pneumologie (Stuttgart, Germany) |d 1990 |g 74(2020), 9 vom: 01. Sept., Seite 611-614 |w (DE-627)NLM012597422 |x 1438-8790 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2020 |g number:9 |g day:01 |g month:09 |g pages:611-614 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1165-6994 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2020 |e 9 |b 01 |c 09 |h 611-614 | ||